Clinical Trial Update: Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China

View source ↗

Summary

A completed clinical trial update assessing the burden of invasive Group B streptococcal disease in young infants in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Group Streptococcal Disease

Snippet

Sponsor: Novartis Vaccines | Conditions: Invasive Group B Streptococcal Disease | Status: COMPLETED